EKFC 2021 (European Kidney Function Consortium) provides a better estimate of kidney function in a Norwegian population, especially in young adults and the elderly, and is recommended by the Norwegian Society for Medical Biochemistry and the Norwegian Society of Renal Medicine.

At the same time, the new formula may result in lower eGFR than previously used formulas. This does not necessarily mean that the patient's kidney function has deteriorated, but may be the result of a more accurate calculation.

In this lunch lecture, Øyvind Skadberg, head of department at SUS, presents the background for the national recommendation and what the transition to the new formula means for the laboratories and the interpretation of test results. 

Here's what you'll learn about:

• why EKFC provides a better estimate of kidney function
• which patient groups are particularly affected by the change
• what the difference between old and new eGFR calculation means
• use of EKFC in children
• what the laboratory needs to pay attention to when transitioning to the new formula.